The action mechanisms of human platelet aggregation induced by Abeta25-35
碩士 === 國立陽明大學 === 藥理學研究所 === 96 === Beta amyloid (Abeta1-40), containing Abeta 25-35 as its toxic peptide, is the major component of Alzheimer's disease (AD) cortical senile plaques. It has been documented that some cases of AD are associated with peripheral abnormalities, including alterations...
Main Authors: | Hsiao-Ting Chou, 周筱婷 |
---|---|
Other Authors: | Wei-Jern Tsai |
Format: | Others |
Language: | zh-TW |
Published: |
2008
|
Online Access: | http://ndltd.ncl.edu.tw/handle/60251779876644258642 |
Similar Items
-
A Study of the Process and Causes of Abeta(25-35) Amyloid Formation
by: Ridinger, Katherine V.
Published: (2011) -
Study of the Pathophysiological Properties of Abeta Aggregates and the Protective Mechanisms of EGb761 against the Cytotoxicity of Abeta Aggregates on PC12 Cells
by: Chang Pei-Teh, et al.
Published: (2002) -
Kihi-to, a herbal traditional medicine, improves Abeta(25–35)-induced memory impairment and losses of neurites and synapses
by: Joyashiki Eri, et al.
Published: (2008-08-01) -
Characterization of Aggretin and Trimucytin,Platelet Aggregation Inducers from Snake Venoms,and Their Action Mechanisms
by: CHOU, MENG CHIEH, et al.
Published: (1997) -
Abeta42 mutants with different aggregation profiles induce distinct pathologies in Drosophila.
by: Koichi Iijima, et al.
Published: (2008-01-01)